Effects of p38 MAPK inhibitor on the rat pain behavior and proinflammatory cytokines in a metastatic bone cancer pain model

Author： Tang Cuiju  

Publisher： Springer Publishing Company

ISSN： 1610-1979

Source： The Chinese-German Journal of Clinical Oncology, Vol.7, Iss.3, 2008-03, pp. : 154-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats

By Roudier Martine   Bain Steven   Dougall William  

Clinical and Experimental Metastasis, Vol. 23, Iss. 3-4, 2006-06 ,pp. : 167-175

Springer Publishing Company

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory pain

By          

Biomedical Reports, Vol. 3, Iss. 5, 2015-01 ,pp. : 703-706

Science Publishers

Access to resources Recommend Favorite

Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain

By          

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 235-244

Spandidos Publications

Access to resources Recommend Favorite

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatinresistant ovarian cancer

By            

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2346-2350

Spandidos Publications

Access to resources Recommend Favorite